Sarcopenia and Systemic Inflammation Response Index Predict Response to Systemic Therapy for Hepatocellular Carcinoma and Are Associated With Immune Cells

BACKGROUND: Systemic therapies, including immune checkpoint inhibitors (ICIs) and tyrosine kinase inhibitors (TKIs), have challenged the use of conventional therapies for hepatocellular carcinoma (HCC). It is crucial to determine which patients could benefit most from combination therapy. This study...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhao, Man, Duan, Xiaoling, Han, Xin, Wang, Jinfeng, Han, Guangjie, Mi, Lili, Shi, Jianfei, Li, Ning, Yin, Xiaolei, Hou, Jiaojiao, Yin, Fei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9024177/
https://www.ncbi.nlm.nih.gov/pubmed/35463384
http://dx.doi.org/10.3389/fonc.2022.854096

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9024177/
https://www.ncbi.nlm.nih.gov/pubmed/35463384
http://dx.doi.org/10.3389/fonc.2022.854096

Ejemplares similares